CORT Financial Facts
Loss from operations: 3.07MNet loss and comprehensive loss: 2.59M
See Full Income Statement
Accounts payable: 4.31M
Property and equipment , net of accumulated depreciation: 145K
See Full Balance Sheet
Corcept Therapeutics (CORT) Earnings
|
Expand Research on CORT
| Next EPS Date | 5/2/24 | EPS Growth Rate | +57.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +17.8% | Revenue Growth Rate | +33.2% |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/10  |
Q310 | -$0.10 | -$0.10 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 3/9/11 | Q410 | -$0.10 | -$0.10 | $0.00 | N/A | $120K | N/A | | | Details | |
| 5/4/11 | Q111 | -$0.09 | -$0.10 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 11/7/11 |
Q311 | -$0.08 | -$0.10 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 3/5/12 | Q411 | -$0.12 | -$0.09 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 5/3/12 | Q112 | -$0.13 | -$0.11 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 8/7/12 | Q212 | -$0.09 | -$0.11 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 10/31/12 |
Q312 | -$0.08 | -$0.09 | +$0.01 | $1.05M | $2.07M | N/A | | | Details |
